Alembic Pharma gets USFDA nod for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1% Read more
Panel Discussion: PPILT meets the patent cliff — Can Goa’s pricing model handle a biologics wave? Read more